BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1346967)

  • 1. A case of chronic lymphocytic leukaemia with myeloid associated antigen.
    Kawamata N; Maruyama Y; Toda S; Takase K; Akiyama H; Sakamaki H; Onozawa Y
    Br J Haematol; 1992 Jan; 80(1):129-30. PubMed ID: 1346967
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression of myeloid associated antigens in chronic lymphocytic leukaemia.
    Pinto A; Zagonel V; Carbone A; Del Vecchio L
    Br J Haematol; 1992 Sep; 82(1):173-5. PubMed ID: 1358172
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunocytochemical investigation of normal and chronic lymphocytic leukaemia lymphocytes reveals unexpectedly frequent reactivity with some myelomonocytic associated antibodies.
    Woessner S; Florensa L; Besses C; Vilà RM; Gallés C; Palou L; Sabrafen JS
    Leuk Res; 1992; 16(5):505-10. PubMed ID: 1378160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloid antigen, CD13, CD14, and/or CD33 expression is restricted to certain lymphoid neoplasms.
    Nakase K; Kita K; Shiku H; Tanaka I; Nasu K; Dohy H; Kyo T; Tsutani H; Kamada N
    Am J Clin Pathol; 1996 Jun; 105(6):761-8. PubMed ID: 8659452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD5 antigen expression in B cell chronic lymphocytic leukaemia.
    Brohée D; Cauchie P; Nève P
    Med Oncol; 1994; 11(3-4):137-8. PubMed ID: 7543349
    [No Abstract]   [Full Text] [Related]  

  • 6. Association of bone marrow growth pattern, coexpression of CD14, and B-cell CD5 antigen density in 45 B-chronic lymphocytic leukemia (B-CLL) patients.
    Paglieroni T; Caggiano V; MacKenzie MR
    Ann N Y Acad Sci; 1992 May; 651():484-5. PubMed ID: 1376066
    [No Abstract]   [Full Text] [Related]  

  • 7. Antigen density in B-cell chronic lymphocytic leukemia.
    Lavabre-Bertrand T; Poncelet P
    Am J Clin Pathol; 1995 Mar; 103(3):375. PubMed ID: 7872264
    [No Abstract]   [Full Text] [Related]  

  • 8. Determination of myeloid antigen expression on childhood acute lymphoblastic leukaemia cells: discrepancies using different monoclonal antibody clones.
    Firat H; Favier R; Adam M; Leverger G; Landman-Parker J; Cayre Y; Douay L
    Leuk Lymphoma; 2001 Jun; 42(1-2):75-82. PubMed ID: 11699224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of myeloid antigen expression on childhood acute lymphoblastic leukaemia cells: discrepancies using different monoclonal antibody clones.
    Firat H; Favier R; Adam M; Leverger G; Landman-Parker J; Cayre Y; Douay L
    Leuk Lymphoma; 2001 Aug; 42(4):675-82. PubMed ID: 11697497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of myeloid antigen markers in adult acute lymphoblastic leukaemia patients: diagnostic and prognostic implications.
    Lauria F; Raspadori D; Martinelli G; Rondelli D; Ventura MA; Farabegoli P; Tosi P; Testoni N; Visani G; Zaccaria A
    Br J Haematol; 1994 Jun; 87(2):286-92. PubMed ID: 7947269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of myelomonocytic antigens is associated with unfavourable clinicoprognostic factors in B-cell chronic lymphocytic leukaemia.
    Pinto A; Del Vecchio L; Carbone A; Roncadin M; Volpe R; Serraino D; Monfardini S; Colombatti A; Zagonel V
    Ann Oncol; 1991 Feb; 2 Suppl 2():107-13. PubMed ID: 2049307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4+, CD33-, CD13-, CD14- acute monoblastic leukaemia.
    Lombard EH; Mansvelt EP
    Acta Haematol; 1992; 87(3):151-2. PubMed ID: 1379402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute myeloid leukaemia with an unusual phenotype: myeloperoxidase (+), CD13 (-), CD14 (-) and CD33 (-).
    Seshi B; Kashyap A; Bennett JM
    Br J Haematol; 1992 Jul; 81(3):374-7. PubMed ID: 1382546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo and in vitro expression of myeloid antigens on B-lineage acute lymphoblastic leukemia cells.
    Hara J; Kawa-Ha K; Yumura-Yagi K; Kurahashi H; Tawa A; Ishihara S; Inoue M; Murayama N; Okada S
    Leukemia; 1991 Jan; 5(1):19-25. PubMed ID: 1705635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistological patterns of myeloid antigens: tissue distribution of CD13, CD14, CD16, CD31, CD36, CD65, CD66 and CD67.
    Bordessoule D; Jones M; Gatter KC; Mason DY
    Br J Haematol; 1993 Mar; 83(3):370-83. PubMed ID: 7683483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD5+ leukemic monocytoid B-cell lymphoma and lymphocytic lymphomas.
    Adami F; Semenzato G; Menestrina F; Chilosi M
    Am J Clin Pathol; 1993 Aug; 100(2):187-8. PubMed ID: 7689294
    [No Abstract]   [Full Text] [Related]  

  • 17. [The role of CDS+ of B-lymphocytes in the physiopathology of the hematopoietic system].
    Pluta A
    Pol Tyg Lek; 1992 Feb 3-10; 47(5-6):148-50. PubMed ID: 1279643
    [No Abstract]   [Full Text] [Related]  

  • 18. Expression pattern of hybrid phenotype in adult acute lymphoblastic leukemia.
    Nakase K; Kita K; Miwa H; Nishii K; Shiku H; Nasu K; Dohy H; Kyo T; Kamada N; Tsutani H
    Cancer Detect Prev; 2001; 25(4):394-405. PubMed ID: 11531016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myelomonocytic associated antigens in early B-chronic lymphocytic leukemia correlate with disease activity.
    Molica S
    Am J Hematol; 1992 Aug; 40(4):319-20. PubMed ID: 1503090
    [No Abstract]   [Full Text] [Related]  

  • 20. Flow cytometric detection of residual disease in acute leukemia by assaying blasts co-expressing myeloid and lymphatic antigens.
    Syrjälä M; Anttila VJ; Ruutu T; Jansson SE
    Leukemia; 1994 Sep; 8(9):1564-70. PubMed ID: 7522295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.